E. S. Casper - Concepedia

Concepedia

Author

E. S. Casper

Memorial Sloan Kettering Cancer Center

Also Known As

E Casper, E S Casper, E. Casper, E. S. Casper, E.S. Casper, ES Casper

37

Publications

3.4K

Citations

17

H-Index

58

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center

ES

About

E. S. Casper is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	18	1.6K
2	Health Sciences	6	6	513
3	Engineering	1	1	20
4	Biochemistry	1	1	20
5	Cardiothoracic Surgery	1	1	247

E. S. Casper

×

22

Publications

3.4K

Citations

17

H-Index

	Year	Citations
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma. Peter W. T. Pisters, L.B. Harrison, Denis H. Y. Leung, Journal of Clinical Oncology	1996	997
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreas cancer Mace L. Rothenberg, Malcolm J. Moore, M. Christine Cripps, Annals of Oncology Surgical OncologyPancreatic CancerPhase Ii TrialGastrointestinal OncologyMedicine	1996	569
Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol. Paul A. Meyers, Richard Görlick, Glenn Heller, Journal of Clinical Oncology	1998	297
Refinement of clinicopathologic staging for localized soft tissue sarcoma of the extremity: a study of 423 adults. Jeffrey J. Gaynor, Charlotte C. Tan, E. S. Casper, Journal of Clinical Oncology	1992	270
A prospective randomized comparison of epirubicin and doxorubicin in patients with advanced breast cancer. K K Jain, E. S. Casper, Nancy L. Geller, Journal of Clinical Oncology Heart FailureBreast OncologyCardiovascular PharmacologyPathologyMultimodality	1985	247
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. Paul B. Chapman, Tina Lester, E. S. Casper, Journal of Clinical Oncology ImmunologyCell DeathPharmacotherapyAdvanced Cancer RefractoryMetronomic Chemotherapy	1987	219
Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. Brian H. Kushner, Paul A. Meyers, William L. Gerald, Journal of Clinical Oncology	1995	164
Lack of efficacy of high-dose leucovorin and fluorouracil in patients with advanced pancreatic adenocarcinoma. John Crown, E. S. Casper, J F Botet, Journal of Clinical Oncology OncologyPancreatic CancerGastrointestinal OncologyMedicine5-Fu 370	1991	126
Randomized trial comparing vindesine plus cisplatin with vinblastine plus cisplatin in patients with non-small cell lung cancer, with an analysis of methods of response assessment Mark G. Kris, R. Gralla, Leonard Kalman, Lung Cancer MedicineCancer ManagementClinical TrialsBronchial NeoplasmCancer Treatment	1985	78
Phase I trial of intramuscularly administered tumor necrosis factor in patients with advanced cancer. Ann A. Jakubowski, E. S. Casper, Janice Gabrilove, Journal of Clinical Oncology Surgical OncologyPathologyPharmacotherapyMetronomic ChemotherapyImmunotherapy	1989	77

Page 1